Modulation of intracellular machinery by β-glycolipids is associated with alteration of NKT lipid rafts and amelioration of concanavalin-induced hepatitis

Molecular Immunology

Volumn 45, Issue 13, 2008, Pages 3517-3525

  Lalazar, Gadi ^a   Ben Ya'acov, Ami ^a   Lador, Adi ^a   Livovsky, Dan M ^a   Pappo, Orit ^a   Preston, Sarah ^a   Hareati, Menahem ^a   Ilan, Yaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Glycolipids; Lipid rafts; NKT cells

Indexed keywords

CONCANAVALIN A; FLOTILLIN 2; GANGLIOSIDE GM1; GLUCOSYLCERAMIDE; GLYCOLIPID; LACTOSYLCERAMIDE; PROTEIN KINASE LCK; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HEPATITIS; LIPID RAFT; LYMPHOCYTE MEMBRANE; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CONCANAVALIN A; GLYCOLIPIDS; HEPATITIS, ANIMAL; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MALE; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 46749126493     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.05.009     Document Type: Article

References (25)

1. Bendelac A., Rivera M.N., Park S.H., and Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15 (1997) 535-562
2. Bendelac A., Teyton L., and Savage P.B. Lipid presentation by CD1: the short and the long lipid story. Nat. Immunol. 3 (2002) 421-422
3. Biburger M., and Tiegs G. Alpha-galactosylceramide-induced liver injury in mice is mediated by TNF-alpha but independent of Kupffer cells. J. Immunol. 175 (2005) 1540-1550
4. Crispe I.N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3 (2003) 51-62
5. Crispe I.N., Giannandrea M., Klein I., John B., Sampson B., and Wuensch S. Cellular and molecular mechanisms of liver tolerance. Immunol. Rev. 213 (2006) 101-118
6. Futerman A.H., and van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 5 (2004) 554-565
7. Hannun Y.A., Luberto C., and Argraves K.M. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40 (2001) 4893-4903
8. Harrington L.E.G.M., Baum L.G., Altman J.D., and Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191 (2000) 1241-1246
9. Helms J.B., and Zurzolo C. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic 5 (2004) 247-254
10. Ilan Y., Ohana M., Pappo O., Margalit M., Lalazar G., Engelhardt D., Rabbani E., and Nagler A. Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. Transplantation 83 (2007) 458-467
11. Kaneko Y., Harada M., Kawano T., Yamashita M., Shibata Y., Gejyo F., Nakayama T., and Taniguchi M. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191 (2000) 105-114
12. Lalazar G., Preston S., Zigmond E., Ben Yaacov A., and Ilan Y. Glycolipids as immune modulatory tools. Mini Rev. Med. Chem. 6 (2006) 1249-1253
13. Lang G.A., Maltsev S.D., Besra G.S., and Lang M.L. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology 112 (2004) 386-396
14. Lopez-Montero I., Rodriguez N., Cribier S., Pohl A., Velez M., and Devaux P.F. Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J. Biol. Chem. 280 (2005) 25811-25819
15. Margalit M., Ghazala S.A., Alper R., Elinav E., Klein A., Doviner V., Sherman Y., Thalenfeld B., Engelhardt D., Rabbani E., and Ilan Y. Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G917-G925
16. Margalit M., Shalev Z., Pappo O., Sklair-Levy M., Alper R., Gomori M., Engelhardt D., Rabbani E., and Ilan Y. Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice. J. Pharmacol. Exp. Ther. 319 (2006) 105-110
17. Nicoletti F., Zaccone P., Xiang M., Magro G., Di Mauro M., Di Marco R., Garotta G., and Meroni P. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine 12 (2000) 315-323
18. Osman Y.K.T., Naito T., Takeda K., Van Kaer L., Okumura K., and Abo T. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 30 (2000) 1919-1928
19. Rouvinski A., Gahali-Sass I., Stav I., Metzer E., Atlan H., and Taraboulos A. Both raft- and non-raft proteins associate with CHAPS-insoluble complexes: some APP in large complexes. Biochem. Biophys. Res. Commun. 308 (2003) 750-758
20. Schumann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., and Tiegs G. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 157 (2000) 1671-1683
21. Shimada Y.I.M., Suzuki H., Hayashi M., Abdul Waheed A., and Ohno-Iwashita Y. Separation of a cholesterol-enriched microdomain involved in T-cell signal transduction. FEBS J. 272 (2005) 5454-5463
22. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1 (2000) 31-39
23. Thomas S., Preda-Pais A., Casares S., and Brumeanu T.D. Analysis of lipid rafts in T cells. Mol. Immunol. 41 (2004) 399-409
24. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., Teneberg S., Wang D., Proia R.L., Levery S.B., Savage P.B., Teyton L., and Bendelac A. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
25. Zigmond E., Preston S., Pappo O., Lalazar G., Margalit M., Shalev Z., Zolotarov L., Friedman D., Alper R., and Ilan Y. Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut 56 (2007) 82-89